Jasenka Piljac Žegarac, PhD

Respiratory syncytial virus, rhinovirus, coronaviruses, and influenza have been associated with postviral wheeze and asthma onset.

Researchers from the National Institute of Allergy and Infectious Diseases are working to develop a universal influenza vaccine.

Researchers were able to successfully use a fully implantable delivery system for treprostinil for adult patients with pulmonary arterial hypertension.

Combination lumacaftor/ivacaftor therapy was found to be safe and effective in patients with cystic fibrosis aged 6 to 11 years.

A large cohort study of critically ill patients with varicella-zoster virus-related community-acquired pneumonia found that significant morbidity and mortality are associated with the disease.

Treatment with full-dose angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers was found to slow disease progression in patients with emphysema.

Over 2278 health subjects were included in a multicenter study of the Seqirus IIV4 quadrivalent inactivated influenza vaccine.